These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 444364)

  • 1. The comparative enzyme-inducing properties of antiepileptic drugs [proceedings].
    Perucca E; Hedges A; Makki K; Hebdige S; Wadsworth J; Richens A
    Br J Clin Pharmacol; 1979 Apr; 7(4):414P-415P. PubMed ID: 444364
    [No Abstract]   [Full Text] [Related]  

  • 2. A comparative study of antipyrine and lignocaine disposition in normal subjects and in patients treated with enzyme-inducing drugs.
    Perucca E; Hedges A; Makki KA; Richens A
    Br J Clin Pharmacol; 1980 Nov; 10(5):491-7. PubMed ID: 7437261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparative study of the relative enzyme inducing properties of anticonvulsant drugs in epileptic patients.
    Perucca E; Hedges A; Makki KA; Ruprah M; Wilson JF; Richens A
    Br J Clin Pharmacol; 1984 Sep; 18(3):401-10. PubMed ID: 6435654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A study of some indirect biochemical markers in the evaluation of enzymatic induction caused by antiepileptic drugs].
    Tutor-Crespo MJ; Hermida-Ameijeiras J; Tutor-Valcarce JC
    Rev Neurol; 2002 Oct 16-31; 35(8):711-6. PubMed ID: 12402220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Calcium metabolism and liver enzyme induction in patients treated with anticonvulsant drugs].
    Tutor JC; Fernández MP; Paz JM; López-Urrutia A
    Med Clin (Barc); 1984 May; 82(19):832-5. PubMed ID: 6145829
    [No Abstract]   [Full Text] [Related]  

  • 6. 3-Trifluoromethyl-alpha-ethylbenzhydrol (RGH-3332). Liver enzyme induction and D-glucaric acid excretion.
    Váradi A
    Arzneimittelforschung; 1978; 28(4):678-9. PubMed ID: 581947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Research on the eventual enzymatic induction activity of cetiedil in rat and man.
    Larousse C; Kergueris MF; Le Normand Y; Visset J
    Int J Clin Pharmacol Ther Toxicol; 1980; 18(5):195-9. PubMed ID: 7390670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Note on the enzyme assay for urinary D-glucaric acid and correlation with rifampicin-induced mixed function oxidase activity.
    Perry W; Jenkins MV
    Int J Clin Pharmacol Ther Toxicol; 1986 Nov; 24(11):609-13. PubMed ID: 3793294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased D-glucaric acid excretion in children with renal disease.
    Németh I; Szeleczki T
    Int J Clin Pharmacol Ther Toxicol; 1980; 18(8):357-60. PubMed ID: 7409939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum LDL cholesterol, the LDL/HDL cholesterol ratio and liver microsomal enzyme induction evaluated by antipyrine kinetics.
    Luoma PV; Sotaniemi EA; Arranto AJ
    Scand J Clin Lab Invest; 1983 Dec; 43(8):671-5. PubMed ID: 6665516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of hepatic enzyme inducing effect of sodium valproate.
    Oxley J; Hedges A; Makki KA; Monks A; Richens A
    Br J Clin Pharmacol; 1979 Aug; 8(2):189-90. PubMed ID: 385027
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of enzyme induction on plasma lipids using antipyrine, phenobarbital, and rifampicin.
    Ohnhaus EE; Kirchhof B; Peheim E
    Clin Pharmacol Ther; 1979 May; 25(5 Pt 1):591-7. PubMed ID: 35298
    [No Abstract]   [Full Text] [Related]  

  • 13. Relationship between changes in drug score, D-glucaric acid excretion, and gamma-glutamyltransferase and beta-glucuronidase serum activities during anticonvulsant treatment.
    Hermida J; Fernández MP; Tutor JC
    Clin Lab; 2002; 48(7-8):415-9. PubMed ID: 12146576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Modification of the action of drugs by inhibition of their metabolism].
    Park BK; Breckenridge AM; Ohnhaus EE
    Recenti Prog Med; 1979 Sep; 67(3):313-45. PubMed ID: 42953
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of enzyme induction on bioavailability of hetacillin in patients treated with anticonvulsants and chlorpromazine.
    Galanopoulou P; Karageorgiou C; Dimakopoulou K
    Eur J Drug Metab Pharmacokinet; 1990; 15(1):15-8. PubMed ID: 2384113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proceedings: Gamma-glutamyl transpeptidase elevation in patients receiving enzyme-inducing anticonvulsant drugs.
    Rosalki SB; Tarlow D; Baylis EM
    Quad Sclavo Diagn; 1973 Mar; 9(1):155-8. PubMed ID: 4151028
    [No Abstract]   [Full Text] [Related]  

  • 17. Possible induction of cholinesterase in epileptic patients treated with anticonvulsant drugs: relationship with lipoprotein levels.
    Tutor-Crespo MJ; Hermida J; Tutor JC
    J Clin Pharmacol; 2004 Sep; 44(9):974-80. PubMed ID: 15317825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Enzyme induction during treatment with isoniazid].
    Micheletti C; Percheron F; Foglietti MJ
    Nouv Presse Med; 1978 Aug 26-Sep 2; 7(28):2484. PubMed ID: 693296
    [No Abstract]   [Full Text] [Related]  

  • 19. Human tolerance of flumecinol (Zixoryn, RGH-3332), its regime and dosage in healthy volunteers.
    Vezekenyi Z; Ferenci J; Radnai B; Horvath T; Past T; Nagy L; Jávor T
    Int J Clin Pharmacol Res; 1983; 3(2):77-88. PubMed ID: 6679516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancement of antipyrine clearance and induction of antipyrine 4-hydroxylation by 3-methylcholanthrene in rats [proceedings].
    Kroos-De Haan MA; Noordhoek J
    Br J Pharmacol; 1980 Jan; 68(1):120P. PubMed ID: 7357140
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.